301 related articles for article (PubMed ID: 16631341)
1. Laparoscopic intraperitoneal hyperthermic chemotherapy for palliation of debilitating malignant ascites.
Garofalo A; Valle M; Garcia J; Sugarbaker PH
Eur J Surg Oncol; 2006 Aug; 32(6):682-5. PubMed ID: 16631341
[TBL] [Abstract][Full Text] [Related]
2. Laparoscopy in the management of peritoneal carcinomatosis.
Garofalo A; Valle M
Cancer J; 2009; 15(3):190-5. PubMed ID: 19556903
[TBL] [Abstract][Full Text] [Related]
3. [Laparoscopic intraperitoneal hyperthermic perfusion in palliation of malignant ascites. Case report].
Graziosi L; Bugiantella W; Cavazzoni E; Donini A
G Chir; 2009 May; 30(5):237-9. PubMed ID: 19505418
[TBL] [Abstract][Full Text] [Related]
4. Laparoscopic hyperthermic intraperitoneal peroperative chemotherapy (HIPEC) in the management of refractory malignant ascites: A multi-institutional retrospective analysis in 52 patients.
Valle M; Van der Speeten K; Garofalo A
J Surg Oncol; 2009 Sep; 100(4):331-4. PubMed ID: 19697441
[TBL] [Abstract][Full Text] [Related]
5. Laparoscopic hyperthermic intraperitoneal chemotherapy (HIPEC) for the treatment of malignant ascites secondary to unresectable peritoneal carcinomatosis from advanced gastric cancer.
Facchiano E; Scaringi S; Kianmanesh R; Sabate JM; Castel B; Flamant Y; Coffin B; Msika S
Eur J Surg Oncol; 2008 Feb; 34(2):154-8. PubMed ID: 17640844
[TBL] [Abstract][Full Text] [Related]
6. B ultrasound-guided hyperthermic intraperitoneal perfusion chemotherapy for the treatment of malignant ascites.
Cui S; Ba M; Tang Y; Liu J; Wu Y; Wang B; Zhang X; Tang H; Zhong S
Oncol Rep; 2012 Oct; 28(4):1325-31. PubMed ID: 22797826
[TBL] [Abstract][Full Text] [Related]
7. Peritoneal mesothelioma treated by induction chemotherapy, cytoreductive surgery, and intraperitoneal hyperthermic perfusion.
Deraco M; Casali P; Inglese MG; Baratti D; Pennacchioli E; Bertulli R; Kusamura S
J Surg Oncol; 2003 Jul; 83(3):147-53. PubMed ID: 12827682
[TBL] [Abstract][Full Text] [Related]
8. Successful palliation of malignant ascites from peritoneal mesothelioma by laparoscopic intraperitoneal hyperthermic chemotherapy.
Patriti A; Cavazzoni E; Graziosi L; Pisciaroli A; Luzi D; Gullà N; Donini A
Surg Laparosc Endosc Percutan Tech; 2008 Aug; 18(4):426-8. PubMed ID: 18716551
[TBL] [Abstract][Full Text] [Related]
9. [Treatment of the peritoneal carcinomatosis by cytoreductive surgery and intraperitoneal hyperthermic chemotherapy (IHPC): postoperative morbidity and mortality and short-term follow-up].
Minicozzi A; Borzellino G; Momo EN; Segattini C; Pitoni F; Steccanella F; De Manzoni G
Ann Ital Chir; 2008; 79(4):231-9. PubMed ID: 19093624
[TBL] [Abstract][Full Text] [Related]
10. Prognostic analysis of clinicopathologic factors in 49 patients with diffuse malignant peritoneal mesothelioma treated with cytoreductive surgery and intraperitoneal hyperthermic perfusion.
Deraco M; Nonaka D; Baratti D; Casali P; Rosai J; Younan R; Salvatore A; Cabras Ad AD; Kusamura S
Ann Surg Oncol; 2006 Feb; 13(2):229-37. PubMed ID: 16444562
[TBL] [Abstract][Full Text] [Related]
11. Hyperthermic intraoperative intraperitoneal chemotherapy with cisplatin and doxorubicin in patients who undergo cytoreductive surgery for peritoneal carcinomatosis and sarcomatosis: phase I study.
Rossi CR; Foletto M; Mocellin S; Pilati P; De SM; Deraco M; Cavaliere F; Palatini P; Guasti F; Scalerta R; Lise M
Cancer; 2002 Jan; 94(2):492-9. PubMed ID: 11900234
[TBL] [Abstract][Full Text] [Related]
12. Cytoreductive surgery followed by intraperitoneal hyperthermic perfusion: analysis of morbidity and mortality in 209 peritoneal surface malignancies treated with closed abdomen technique.
Kusamura S; Younan R; Baratti D; Costanzo P; Favaro M; Gavazzi C; Deraco M
Cancer; 2006 Mar; 106(5):1144-53. PubMed ID: 16456817
[TBL] [Abstract][Full Text] [Related]
13. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy improves survival in selected patients with peritoneal carcinomatosis from abdominal and pelvic malignancies: results of 21 cases.
Yang XJ; Li Y; al-shammaa Hassan AH; Yang GL; Liu SY; Lu YL; Zhang JW; Yonemura Y
Ann Surg Oncol; 2009 Feb; 16(2):345-51. PubMed ID: 19018599
[TBL] [Abstract][Full Text] [Related]
14. Treatment and prevention of malignant ascites associated with disseminated intraperitoneal malignancies by aggressive combined-modality therapy.
Loggie BW; Perini M; Fleming RA; Russell GB; Geisinger K
Am Surg; 1997 Feb; 63(2):137-43. PubMed ID: 9012427
[TBL] [Abstract][Full Text] [Related]
15. [A patient with stage IIIc ovarian cancer with massive ascites who was chemotherapy resistant showed complete response with intraperitoneal hyperthermic chemoperfusion].
Kobayashi K; Fujimoto S; Takahashi M; Mutou T; Toyosawa T; Ohtsuka Y; Ogasawara T
Gan To Kagaku Ryoho; 2003 Oct; 30(11):1726-8. PubMed ID: 14619504
[TBL] [Abstract][Full Text] [Related]
16. Cytoreduction combined with intraperitoneal hyperthermic perfusion chemotherapy in advanced/recurrent ovarian cancer patients: The experience of National Cancer Institute of Milan.
Raspagliesi F; Kusamura S; Campos Torres JC; de Souza GA; Ditto A; Zanaboni F; Younan R; Baratti D; Mariani L; Laterza B; Deraco M
Eur J Surg Oncol; 2006 Aug; 32(6):671-5. PubMed ID: 16621425
[TBL] [Abstract][Full Text] [Related]
17. Incidence of postoperative pancreatic fistula and hyperamylasemia after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Kusamura S; Baratti D; Antonucci A; Younan R; Laterza B; Oliva GD; Gavazzi C; Deraco M
Ann Surg Oncol; 2007 Dec; 14(12):3443-52. PubMed ID: 17909918
[TBL] [Abstract][Full Text] [Related]
18. Multicystic and well-differentiated papillary peritoneal mesothelioma treated by surgical cytoreduction and hyperthermic intra-peritoneal chemotherapy (HIPEC).
Baratti D; Kusamura S; Nonaka D; Oliva GD; Laterza B; Deraco M
Ann Surg Oncol; 2007 Oct; 14(10):2790-7. PubMed ID: 17661150
[TBL] [Abstract][Full Text] [Related]
19. Outcomes of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal mesothelioma: the Australian experience.
Chua TC; Yan TD; Morris DL
J Surg Oncol; 2009 Feb; 99(2):109-13. PubMed ID: 19016259
[TBL] [Abstract][Full Text] [Related]
20. [Adjuvant hyperthermic intraperitoneal chemotherapy in patients with colorectal cancer at risk of carcinomatosis: preliminary experience of a single centre].
Virzi S; Iusco D; Grassi A; Navarra G; Ismail I; Panetta A; Bonomi S
Chir Ital; 2008; 60(6):825-30. PubMed ID: 19256273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
